The American Clinical Laboratory Association (ACLA) has filed a lawsuit alleging the new Medicare reimbursement system for lab tests goes against what Congress intended in the Protecting Access to Medicare Act (PAMA) and would reduce payments to labs by about $670 million in 2018.

Scientists from the University of North Carolina Lineberger Comprehensive Cancer Center have developed a software program capable of predicting which tumor-specific markers will appear on the surface of leukemia cells in patients who received stem cells. Findings were presented at the 59th Annual American Society for Hematology Annual Meeting.

Researchers from the Keck Medicine of University of Southern California (USC) have found using a recording device during surgical procedures can differentiate between novice and expert surgeons. Findings, published in The Journal of Urology, aimed to improve the evaluation process of surgeon proficiency and standardizing credentialing.

Millennial patients know less about their health benefits, are less likely to pay their medical bills in full and often don’t save for medical expenses, according to a survey published by TransUnion Healthcare.

In recognition of the nation’s highest quality hospitals, The Leapfrog Group, an independent nonprofit hospital watchdog organization, announced today the recipients of its 2017 Top Hospitals award. This year, New Jersey, California, Florida and Massachusetts had strong showings, with 10 or more hospitals in each of those states receiving the elite distinction.

The Hospital Readmissions Reduction Program (HRRP) introduced by the Affordable Care Act (ACA) hasn’t been beloved by hospitals who have been penalized by it, but now new studies have given physicians and administrators new reasons to oppose it: It may be jeopardizing patient care.

Health insurers expect the repeal of the Affordable Care Act (ACA)’s individual mandate will make the individual insurance market worse, particularly for customers who don’t have employer-sponsored coverage but make too much money to receive subsidies to lower their premiums.

McKesson’s board failed to audit the company’s methods to detect suspicious shipments of opioid painkillers, even after agreeing to do so in a court settlement, according to board minutes unsealed as part of a shareholder lawsuit.